STOCK TITAN

Akebia Therapeutics to Present at Jefferies Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Akebia Therapeutics, Inc. (Nasdaq: AKBA) will be presenting at the Jefferies Healthcare Conference on June 9, 2022, at 10:30 a.m. ET. CEO John Butler will represent the company, which focuses on improving the lives of those affected by kidney disease. The conference is scheduled for June 8-10, 2022, in New York. Investors can access a live webcast of the presentation on the company’s website, with a replay available for 90 days after. Akebia, established in 2007 and based in Cambridge, Massachusetts, is dedicated to developing therapeutics for kidney disease.

Positive
  • None.
Negative
  • None.

CAMBRIDGE, Mass., June 3, 2022  /PRNewswire/ -- Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that John Butler, Chief Executive Officer, will present at the Jefferies Healthcare Conference on Thursday, June 9, 2022 at 10:30 a.m. ET. The Jefferies Healthcare Conference will take place June 8-10, 2022, in New York.

A live webcast of the presentation can be accessed through the Investors section of Akebia's website at https://ir.akebia.com. A replay of the webcast will also be available for approximately 90 days following the conference through the Investors section of Akebia's website at https://ir.akebia.com.

About Akebia Therapeutics

Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. Akebia was founded in 2007 and is headquartered in Cambridge, Massachusetts. For more information, please visit our website at www.akebia.com, which does not form a part of this release.

Akebia Therapeutics Contact
Mercedes Carrasco
Mcarrasco@akebia.com 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/akebia-therapeutics-to-present-at-jefferies-healthcare-conference-301560862.html

SOURCE Akebia Therapeutics

FAQ

When will Akebia Therapeutics present at the Jefferies Healthcare Conference?

Akebia Therapeutics will present on June 9, 2022, at 10:30 a.m. ET.

Who is presenting for Akebia Therapeutics at the conference?

CEO John Butler will present for Akebia Therapeutics.

What are the dates for the Jefferies Healthcare Conference?

The conference will take place from June 8-10, 2022.

Where can I watch the Akebia Therapeutics presentation?

The presentation can be viewed live on Akebia's Investors website.

How long will the Akebia Therapeutics presentation replay be available?

The replay will be available for approximately 90 days after the conference.

Akebia Therapeutics, Inc.

NASDAQ:AKBA

AKBA Rankings

AKBA Latest News

AKBA Stock Data

399.27M
207.87M
2.09%
27.37%
5.48%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States of America
CAMBRIDGE